Study S000162

Comparison of Oral Semaglutide With Matched Oral Semaglutide Placebo as an Early Treatment for Latino Adults With Type 2 Diabetes Receiving Enhanced Lifestyle Care

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04938388
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: TRIPLE
Status: TERMINATED
Enrollment: 12
Start: 2022-01-29
Primary completion: 2023-02-16
Lead sponsor: Sansum Diabetes Research Institute
Conditions: Diabetes Mellitus, Type 2; Glucose Metabolism Disorders (Including Diabetes Mellitus)
Interventions: DRUG:Semaglutide Pill; DIETARY_SUPPLEMENT:Fresh organic vegetables
Results posted: FALSE

Registered primary outcomes

HbA1c < 7.0% [At 50 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.